Showing results (251-260 of 316) with videos related to

Sort By:
Pageof 32
Oncotarget|October 6, 2017
A cerebrospinal fluid microRNA signature as biomarker for glioblastomaJohnny C Akers, Wei Hua, Hongying Li, et al.
Cancer Immunology, Immunotherapy : CII|April 18, 2013
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomideLuis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, et al.
Oncotarget|June 11, 2015
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibitionYing Shen, Jie Li, Masayuki Nitta, et al.
JCO Precision Oncology|June 26, 2025
Minimum Technical Preanalytical, Patient, and Clinical Context Data Elements for Cerebrospinal Fluid Liquid Biopsy: Recommendations for Public Database SubmissionsStephen J Bagley, Nike Beaubier, Leonora Balaj, et al.
Blood|July 20, 2019
Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphomaMatthew J Frigault, Jorg Dietrich, Maria Martinez-Lage, et al.
Cancers|July 12, 2025
A Review of Emerging Immunotherapeutic Strategies for IDH-Mutant GliomaMasih Tazhibi, Eric P Grewal, Rishab Ramapriyan, et al.
Oncoimmunology|September 14, 2020
IDH-mutant gliomas harbor fewer regulatory T cells in humans and miceLeland G Richardson, Linda T Nieman, Anat O Stemmer-Rachamimov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of GliomasKoushik Muralidharan, Anudeep Yekula, Julia L Small, et al.
Journal of Extracellular Vesicles|September 1, 2015
Extracellular RNAs: development as biomarkers of human diseaseJoseph F Quinn, Tushar Patel, David Wong, et al.
Neurosurgery|November 5, 2025
Multi-Institutional Assessment of Circulating Cell-Free DNA in Cerebrospinal Fluid Facilitates Central Nervous System Lymphoma Diagnosis and Treatment InitiationBriana C Prager, Mihir Gupta, Timothy R West, et al.
Pageof 32